Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
Mycobacterium tuberculosis hijacks host TRIM21- and NCOA4-dependent ferritinophagy to enhance intracellular growth
Youchao Dai, … , Xinchun Chen, Yi Cai
Youchao Dai, … , Xinchun Chen, Yi Cai
Published April 17, 2023
Citation Information: J Clin Invest. 2023;133(8):e159941. https://doi.org/10.1172/JCI159941.
View: Text | PDF
Research Article Immunology Infectious disease

Mycobacterium tuberculosis hijacks host TRIM21- and NCOA4-dependent ferritinophagy to enhance intracellular growth

  • Text
  • PDF
Abstract

Ferritin, a key regulator of iron homeostasis in macrophages, has been reported to confer host defenses against Mycobacterium tuberculosis (Mtb) infection. Nuclear receptor coactivator 4 (NCOA4) was recently identified as a cargo receptor in ferritin degradation. Here, we show that Mtb infection enhanced NCOA4-mediated ferritin degradation in macrophages, which in turn increased the bioavailability of iron to intracellular Mtb and therefore promoted bacterial growth. Of clinical relevance, the upregulation of FTH1 in macrophages was associated with tuberculosis (TB) disease progression in humans. Mechanistically, Mtb infection enhanced NCOA4-mediated ferritin degradation through p38/AKT1- and TRIM21-mediated proteasomal degradation of HERC2, an E3 ligase of NCOA4. Finally, we confirmed that NCOA4 deficiency in myeloid cells expedites the clearance of Mtb infection in a murine model. Together, our findings revealed a strategy by which Mtb hijacks host ferritin metabolism for its own intracellular survival. Therefore, this represents a potential target for host-directed therapy against tuberculosis.

Authors

Youchao Dai, Chuanzhi Zhu, Wei Xiao, Kaisong Huang, Xin Wang, Chenyan Shi, Dachuan Lin, Huihua Zhang, Xiaoqian Liu, Bin Peng, Yi Gao, Cui Hua Liu, Baoxue Ge, Stefan H.E. Kaufmann, Carl G. Feng, Xinchun Chen, Yi Cai

×

Figure 1

Expression of ferritin is associated with Mtb growth in macrophages.

Options: View larger image (or click on image) Download as PowerPoint
Expression of ferritin is associated with Mtb growth in macrophages.
(A)...
(A) Quantitative reverse transcriptase PCR (RT-qPCR) analysis of FTH1 and FTL mRNA abundance in PBMCs from healthy controls (HC, n = 35), TB patients (TB, n = 30), and non-TB pneumonia patients (PN, n = 25). (B) RT-qPCR analysis of FTH1 and FTL at different time points (2, 6, 12, and 24 hours) in THP-1–derived macrophages infected or not infected with H37Rv (MOI = 3). (C and D) Immunoblot analysis of FTH1 and FTL at different time points (0, 6, 12, and 24 hours) in THP-1–derived macrophages after infection with the indicated MOI (0, 1, 3, or 10). (E–G) THP-1–derived macrophages were infected for 72 hours with Mtb strain H37Ra carrying a dual-color reporter that comprises a constitutively green (Emerald) and a tetracycline-inducible red (TagRFP) fluorescent protein. Tetracycline (500 ng/mL) was added 24 hours before analysis of the live or dead status of the H37Ra strain in macrophages by flow cytometry (E). (F and G) RT-qPCR analysis (F) and immunoblot analysis (G) of FTH1 and FTL in negative control, uninfected, and harboring live or dead H37Ra macrophages. (H) Immunoblot analysis of FTH1 in FTH1-knockdown THP-1–derived macrophages. (I) Intracellular H37Rv CFU levels in FTH1-knockdown THP-1–derived macrophages treated with ferrous lactate (20 μM), DFO (25 μM), or vehicle. (J) THP-1–derived macrophages with FTH1 knockdown were pretreated with ferrous lactate (20 μM) for 24 hours. Then CFUs of intracellular H37Rv were assessed in the presence of DFO (25 μM) or vehicle. Data in F–J are representative of 2 or 3 independent experiments. Data are presented as means ± SD; *P < 0.05, **P < 0.01, ***P < 0.001, ****P < 0.0001 by 1-way ANOVA with Tukey’s post hoc test (A and F) or Student’s 2-tailed unpaired t test (I and J).

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts